Topics
Glioblastoma | Treatment | Chemotherapy | Temozolomide | NEO212
Home > Publications > Topics > Glioblastoma > Treatment > Chemotherapy > Temozolomide > NEO212
*Minea
RO, Thein TZ, Yang Z, Campan M, Ward PM, Schönthal AH, Chen
TC.
NEO212,
temozolomide conjugated to NEO100, exerts superior therapeutic
activity over temozolomide in preclinical chemoradiation models of
glioblastoma.
Neurooncol
Adv.
2024 Jun 11;6(1):vdae095. doi:
10.1093/noajnl/vdae095. PMID:
39022643. Laboratory investigation. ˍ